Dysbiosis contributes to chronic constipation development via regulation of serotonin transporter in the intestine

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Cao, Hailong ^a,b   Liu, Xiang ^a   An, Yingying ^a   Zhou, Guoqiong ^a   Liu, Yanrong ^c   Xu, Mengque ^a   Dong, Wenxiao ^a   Wang, Sinan ^a   Yan, Fang ^a,b   Jiang, Kui ^a   Wang, Bangmao ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c Tianjin Joint Academy of Biomedicine and Technology   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; SEROTONIN TRANSPORTER;

ADOLESCENT; ADULT; ANIMAL; CONSTIPATION; DISEASE MODEL; DISEASE PREDISPOSITION; DYSBIOSIS; FECAL MICROBIOTA TRANSPLANTATION; FECES; FEMALE; GENE EXPRESSION; GENETICS; HUMAN; INTESTINE FLORA; INTESTINE MUCOSA; MALE; METABOLISM; MICROBIOLOGY; MIDDLE AGED; MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; ANIMALS; CONSTIPATION; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; DYSBIOSIS; FECAL MICROBIOTA TRANSPLANTATION; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; GENE EXPRESSION; HUMANS; INTESTINAL MUCOSA; MALE; MICE; MIDDLE AGED; RNA, MESSENGER; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; YOUNG ADULT;

EID: 85028766330     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-10835-8     Document Type: Article

References (67)

1. Rao, S. S., Rattanakovit, K. & Patcharatrakul, T. Diagnosis and management of chronic constipation in adults. Nat Rev Gastroenterol Hepatol 13, 295-305 (2016).
2. Suares, N. C. & Ford, A. C. Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-Analysis. Am J Gastroenterol 106, 1582-1591; quiz 1581, 1592 (2011).
3. Park, K. S. et al. Practical treatments for constipation in Korea. Korean J Intern Med 27, 262-270 (2012).
4. Ge, X. et al. Potential role of fecal microbiota from patients with slow transit constipation in the regulation of gastrointestinal motility. Sci Rep 7, 441 (2017).
5. Brenner, D. M. & Shah, M. Chronic Constipation. Gastroenterol Clin North Am 45, 205-216 (2016).
6. Parthasarathy, G. et al. Relationship Between Microbiota of the Colonic Mucosa vs Feces and Symptoms, Colonic Transit, and Methane Production in Female Patients With Chronic Constipation. Gastroenterology 150, 367-379.e1 (2016).
7. Attaluri, A., Jackson, M., Valestin, J. & Rao, S. S. Methanogenic flora is associated with altered colonic transit but not stool characteristics in constipation without IBS. Am J Gastroenterol 105, 1407-1411 (2010).
8. Simrén, M. et al. Intestinal microbiota in functional bowel disorders: A Rome foundation report. Gut 62, 159-176 (2013).
9. Clemente, J. C., Ursell, L. K., Parfrey, L. W. & Knight, R. The impact of the gut microbiota on human health: An integrative view. Cell 148, 1258-1270 (2012).
10. Zhu, L. et al. Structural changes in the gut microbiome of constipated patients. Physiol Genomics 46, 679-686 (2014).
11. Zhao, Y. & Yu, Y. B. Intestinal microbiota and chronic constipation. Springerplus 5, 1130 (2016).
12. Sia, T. C. et al. Is serotonin in enteric nerves required for distension-evoked peristalsis and propulsion of content in guinea-pig distal colon. Neuroscience 240, 325-335 (2013).
13. Kim, Y. S. et al. The effect of tegaserod on symptoms and quality of life in korean women with irritable bowel syndrome with constipation. J Neurogastroenterol Motil 16, 61-70 (2010).
14. Patel, B. A. et al. The TNF-α antagonist etanercept reverses age-related decreases in colonic SERT expression and faecal output in mice. Sci Rep 7, 42754 (2017).
15. Coates, M. D. et al. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology 126, 1657-1664 (2004).
16. Jin, D. C. et al. M. Regulation of the serotonin transporter in the pathogenesis of irritable bowel syndrome. World J Gastroenterol 22, 8137-8148 (2016).
17. Bhattarai, Y. et al. Human-derived gut microbiota modulates colonic secretion in mice by regulating 5-HT3 receptor expression via acetate production. Am J Physiol Gastrointest Liver Physiol 313, G80-80G87 (2017).
18. Yano, J. M. et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 161, 264-276 (2015).
19. Nzakizwanayo, J. et al. Escherichia coli Nissle 1917 enhances bioavailability of serotonin in gut tissues through modulation of synthesis and clearance. Sci Rep 5, 17324 (2015).
20. Latorre, E. et al. Listeria monocytogenes Inhibits Serotonin Transporter in Human Intestinal Caco-2 Cells. Microb Ecol 72, 730-739 (2016).
21. Mawe, G. M. & Hoffman, J. M. Serotonin signalling in the gut-functions, dysfunctions and therapeutic targets. Nat Rev Gastroenterol Hepatol 10, 473-486 (2013).
22. El-Salhy, M., Gilja, O. H., Hatlebakk, J. G. & Hausken, T. Stomach antral endocrine cells in patients with irritable bowel syndrome. Int J Mol Med 34, 967-974 (2014).
23. Sundaramurthy, S. et al. Modulation of serotonin transporter function by kappa-opioid receptor ligands. Neuropharmacology 113, 281-292 (2016).
24. Esmaili, A. et al. Enteropathogenic Escherichia coli infection inhibits intestinal serotonin transporter function and expression. Gastroenterology 137, 2074-2083 (2009).
25. Guarino, M. et al. Progesterone receptors and serotonin levels in colon epithelial cells from females with slow transit constipation. Neurogastroenterol Motil 23, 575-575e210 (2011).
26. Dvorakova, M., Nenutil, R. & Bouchal, P. Transgelins, cytoskeletal proteins implicated in different aspects of cancer development. Expert Rev Proteomics 11, 149-165 (2014).
27. Kabouridis, P. S. et al. Microbiota controls the homeostasis of glial cells in the gut lamina propria. Neuron 85, 289-295 (2015).
28. Reigstad, C. S. et al. Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells. FASEB J 29, 1395-1403 (2015).
29. Quigley, E. M. & Spiller, R. C. Constipation and the Microbiome: Lumen Versus Mucosa. Gastroenterology 150, 300-303 (2016).
30. Kim, S. E. et al. Change of Fecal Flora and Effectiveness of the Short-Term VSL#3 Probiotic Treatment in Patients With Functional Constipation. J Neurogastroenterol Motil 21, 111-120 (2015).
31. Lynch, S. V. & Pedersen, O. The Human Intestinal Microbiome in Health and Disease. N Engl J Med 375, 2369-2379 (2016).
32. McQuade, R. M. et al. Role of oxidative stress in oxaliplatin-induced enteric neuropathy and colonic dysmotility in mice. Br J Pharmacol 173, 3502-3521 (2016).
33. Gwee, K. A. et al. Assessment of the Asian Neurogastroenterology and Motility Association Chronic Constipation Criteria: An Asian Multicenter Cross-sectional Study. J Neurogastroenterol Motil (2016).
34. Zhang, J. et al. Olanzapine May Inhibit Colonic Motility Associated with the 5-HT Receptor and Myosin Light Chain Kinase. Psychiatry Investig 13, 232-238 (2016).
35. de Meij, T. G. et al. Characterization of Microbiota in Children with Chronic Functional Constipation. PLoS One 11, e0164731 (2016).
36. Khalif, I. L., Quigley, E. M., Konovitch, E. A. & Maximova, I. D. Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation. Dig Liver Dis 37, 838-849 (2005).
37. Gerritsen, J., Smidt, H., Rijkers, G. T. & de Vos, W. M. Intestinal microbiota in human health and disease: The impact of probiotics. Genes Nutr 6, 209-240 (2011).
38. Cudmore, S., Doolan, A., Lacey, S. & Shanahan, F. A randomised, double-blind, placebo-controlled clinical study: The effects of a synbiotic, Lepicol, in adults with chronic, functional constipation. Int J Food Sci Nutr 1-12 (2016).
39. Collins, B. R. & O'Brien, L. Prevention and management of constipation in adults. Nurs Stand 29, 49-58 (2015).
40. Tabbers, M. M. & Benninga, M. A. Constipation in children: fibre and probiotics. BMJ Clin Evid 2015 (2015).
41. Derrien, M., Vaughan, E. E., Plugge, C. M. & de Vos, W. M. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int J Syst Evol Microbiol 54, 1469-1476 (2004).
42. Zhang, Z. et al. Caffeic acid ameliorates colitis in association with increased Akkermansia population in the gut microbiota of mice. Oncotarget 7, 31790-31799 (2016).
43. Shin, N. R. W. et al. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut 63, 727-735 (2014).
44. Kang, C. S. et al. Extracellular vesicles derived from gut microbiota, especially Akkermansia muciniphila, protect the progression of dextran sulfate sodium-induced colitis. PLoS One 8, e76520 (2013).
45. Everard, A. et al. Cross-Talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci USA 110, 9066-9071 (2013).
46. Dingemanse, C. et al. Akkermansia muciniphila and Helicobacter typhlonius modulate intestinal tumor development in mice. Carcinogenesis 36, 1388-1396 (2015).
47. Weitman, E. S. et al. Obesity impairs lymphatic fluid transport and dendritic cell migration to lymph nodes. PLoS One 8, e70703 (2013).
48. Heredia, D. J. et al. K. Localized release of serotonin (5-hydroxytryptamine) by a fecal pellet regulates migrating motor complexes in murine colon. Gastroenterology 136, 1328-1338 (2009).
49. Bayguinov, P. O., Hennig, G. W. & Smith, T. K. Calcium activity in different classes of myenteric neurons underlying the migrating motor complex in the murine colon. J Physiol 588, 399-421 (2010).
50. Gershon, M. D. 5-Hydroxytryptamine (serotonin) in the gastrointestinal tract. Curr Opin Endocrinol Diabetes Obes 20, 14-21 (2013).
51. Barnes, K. J. et al. J. Control of intrinsic pacemaker frequency and velocity of colonic migrating motor complexes in mouse. Front Neurosci 8, 96 (2014).
52. Drossman, D. A. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 130, 1377-1390 (2006).
53. Emmanuel, A., Cools, M., Vandeplassche, L. & Kerstens, R. Prucalopride improves bowel function and colonic transit time in patients with chronic constipation: An integrated analysis. Am J Gastroenterol 109, 887-894 (2014).
54. Zheng, P. et al. Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host's metabolism. Mol Psychiatry 21, 786-796 (2016).
55. Seo, S. U. et al. Distinct Commensals Induce Interleukin-1β via NLRP3 Inflammasome in Inflammatory Monocytes to Promote Intestinal Inflammation in Response to Injury. Immunity 42, 744-755 (2015).
56. Bonnet, M. et al. Colonization of the human gut by E. coli and colorectal cancer risk. Clin Cancer Res 20, 859-867 (2014).
57. Le, R. T. et al. Intestinal microbiota determines development of non-Alcoholic fatty liver disease in mice. Gut 62, 1787-1794 (2013).
58. Seki, E. et al. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med 13, 1324-1332 (2007).
59. Elamin, E. et al. Effects of ethanol and acetaldehyde on tight junction integrity: in vitro study in a three dimensional intestinal epithelial cell culture model. PLoS One 7, e35008 (2012).
60. Alemi, F. et al. The receptor TGR5 mediates the prokinetic actions of intestinal bile acids and is required for normal defecation in mice. Gastroenterology 144, 145-154 (2013).
61. Kakino, M. et al. Laxative effects of agarwood on low-fiber diet-induced constipation in rats. BMC Complement Altern Med 10, 68 (2010).
62. Suo, H. et al. Therapeutic effect of activated carbon-induced constipation mice with Lactobacillus fermentum Suo on treatment. Int J Mol Sci 15, 21875-21895 (2014).
63. Li, T., Lu, X. & Yang, X. Stachyose-enriched α-galacto-oligosaccharides regulate gut microbiota and relieve constipation in mice. J Agric Food Chem 61, 11825-11831 (2013).
64. Lee, J. R. et al. Gut microbiota and tacrolimus dosing in kidney transplantation. PLoS One 10, e0122399 (2015).
65. Yasir, M. et al. Comparison of the gut microbiota of people in France and Saudi Arabia. Nutr Diabetes 5, e153 (2015).
66. Schloss, P. D., Gevers, D. & Westcott, S. L. Reducing the effects of PCR amplification and sequencing artifacts on 16S rRNA-based studies. PLoS One 6, e27310 (2011).
67. Schloss, P. D. et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 75, 7537-7541 (2009).